Sowell Financial Services LLC Biocryst Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $348,730 - $596,099	-30,167 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$11.18 - $15.46 $100 - $139	9 Added 0.03%	30,167 $418,000
Q3 2021 Nov 04, 2021	SELL	$14.21 - $17.65 $31,645 - $39,306	-2,227 Reduced 6.88%	30,158 $433,000
Q2 2021 Aug 05, 2021	BUY	$9.5 - $17.24 $73,615 - $133,592	7,749 Added 31.45%	32,385 $512,000
Q1 2021 May 07, 2021	BUY	$7.37 - $13.61 $95,375 - $176,127	12,941 Added 110.65%	24,636 $318,000
Q4 2020 Jan 13, 2021	BUY	$3.37 - $8.61 $11,215 - $28,654	3,328 Added 39.78%	11,695 $87,000
Q3 2020 Nov 12, 2020	BUY	$3.43 - $5.53 $24,637 - $39,721	7,183 Added 606.67%	8,367 $29,000
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $2,249 - $6,642	1,184 New	1,184 $6,000

260

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.